Effect of soy milk on warfarin efficacy

Annals of Pharmacotherapy

Volumn 36, Issue 12, 2002, Pages 1893-1896

  Cambria Kiely, Josie A ^a  

^a Fallon Clinic   (United States)

Author keywords

Soy protein; Warfarin

Indexed keywords

ATENOLOL; DIGOXIN; LANSOPRAZOLE; LORAZEPAM; SOYBEAN PROTEIN; WARFARIN; ANTICOAGULANT AGENT;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; FOOD DRUG INTERACTION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTRIGLYCERIDEMIA; INTERNATIONAL STANDARD UNIT; LABORATORY TEST; MALE; MILK; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; INTERNATIONAL NORMALIZED RATIO; SOYBEAN;

AGED; ANTICOAGULANTS; FOOD-DRUG INTERACTIONS; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; SOYBEAN PROTEINS; SOYBEANS; WARFARIN;

EID: 0036894741     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1C160     Document Type: Article

References (23)

1. Ansell JE. Oral anticoagulant therapy: 50 Years later. Arch Intern Med 1993;153:586-96.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham study. Arch Intern Med 1987; 147:1561-4.
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57.
4. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-6.
5. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
6. Setchell KD, Cassidy A. Dietary isoflavones: Biological effects and relevance to human health. J Nutr 1999;129:758S-67S.
7. Wong WW, Smith EO, Stuff JE, Hachey DL, Heird WC, Pownell HJ. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr 1998;68(6 suppl):1385S-9S.
8. Erdman JW Jr. AHA Science Advisory: Soy protein and cardiovascular disease: A statement for healthcare professionals from the Nutrition Committee of the AHA. Circulation 2000;102:2555-9.
9. Clarkson TB, Anthony MS, Morgan TM. Inhibition of postmenopausal atherosclerosis progression: A comparison of the effects of conjugated equine estrogens and soy phytoestrogens. J Clin Endocrinol Metab 2001; 86:41-7.
10. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.
11. Sorano GG, Biondi G, Conti M, Mameli G, Licheri D, Marongiu F. Controlled vitamin K content diet for improving the management of poorly controlled anticoagulated patients: A clinical practice proposal. Hemostasis 1993;23:77-82.
12. Li AP, Kaminski DL, Rasmussen A. Substrates of human hepatic cytochrome P450. Toxicology 1995;104:1-8.
13. Miners JO, Birkett DJ. Cytochrome P4502C9: An enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 1998;45:525-38.
14. Hunter J, Hirst BH. Intestinal secretion of drugs: The role of p-glycoprotein and related drug efflux systems in limiting oral drug absorption. Advanc Drug Del Rev 1997;25:129-57.
15. Benet LZ, Wu CY, Hebert MF, Wacher VJ. Intestinal drug metabolism and antitransport processes: A potential paradigm shift in oral drug delivery. J Control Rel 1996;39:139-43.
16. Evans AM. Influences of dietary components on the gastrointestinal metabolism and transport of drugs. Ther Drug Monit 2001;22:131-6.
17. Helsby NA, Chipman JK, Gescher A, Kerr D. Inhibition of mouse and human CYP 1A- and 2E1-dependent substrate metabolism by the isoflavonoids genistein and equol. Food Chem Toxicol 1998;36:375-82.
18. Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001;119(1 suppl):8S-21S.
19. Kaminsky LS, Zhang ZH. Human P450 metabolism of warfarin. Pharmacol Ther 1997;73:67-74.
20. Albertazzi P, Pansini F, Bonaccorsi G, Zanotti L, Forini E, De Aloysio D. The effect of dietary soy supplementation on hot flashes. Obstet Gynecol 1998;91:6-11.
21. Setchell KD. Absorption and metabolism of soy isoflavones - From food to dietary supplements in adults to infants. J Nutr 2000;130:654S-5S.
22. 1) content of foods in the US Food and Drug Administration's total diet study. J Agric Food Chem 1995;43:1574-9.
23. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.